Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2017.240 | Optimal timing of umbilical cord clamping for term babies with natural birth – a randomised open-labelled trial |
Prof. TAM Wing Hung 譚永雄 |
| 2015.231 | Cardiovascular risk in women with a prior history of pre-eclampsia |
Prof. TAM Wing Hung 譚永雄 |
| 2017.245 | Association of genetic variations in human genome with length of second stage of labor – validating the prediction model using pregnancy cohort from Hong Kong |
Prof. TAM Wing Hung 譚永雄 |
| 2017.070 | The effectiveness of myoinositol nutritional supplementation in the prevention of gestational diabetes mellitus – a randomised, double-blind, placebo-controlled trial |
Prof. TAM Wing Hung 譚永雄 |
| 2018.439 | Iodine Survey (pregnant women and lactating mothers) |
Prof. TAM Wing Hung 譚永雄 |
| 2018.006 | Effectiveness of a community based early nutrition program on promoting breastfeeding and optimizing infant growth and diet quality |
Prof. TAM Wing Hung 譚永雄 |
| 2018.024 | Maternal overnutrition and offspring’s future health - to explore the role of gut microbiota on children’s cardiometabolic risk and neurocognitive development |
Prof. TAM Wing Hung 譚永雄 |
| 2008.502 | Hormonal Responses to Whole Body Vibration Exercise with Different Vibration Protocols in Elderly Individuals: A Randomized Cross-Over Trial | Mr Tam Tsz King Bjorn |
| 2023.144 | Atrioventricular node ablation with pulse field energy in patients for rate control in patients with persistent atrial fibrillation |
Dr. TAM Tsz Kin 譚子健 |
| 2023.600 | Leadless Pacemaker Comparison Study |
Dr. TAM Tsz Kin 譚子健 |
| 2023.467 | Peri-operative Hemodynamic Data in Predicting Procedural Outcomes using Machine Learning |
Dr. TAM Tsz Kin 譚子健 |
| 2025.163 | Pulsed field ablation for cavotricuspid isthmus dependent atrial flutter cohort study | Prof. TAM Tsz Kin |
| 2025.059 | Personalizing Heart failure Device therapy by ECG imaging – a multicenter randomized controlled trial |
Prof. TAM Tsz Kin 譚子健 |
| 2024.399 | Combined Leadless Pacemaker and Left Atrial Appendage Occlusion Registry |
Prof Tam Tsz Kin 譚子健 |
| 2024.658 | Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia (OPTION-A) |
Prof. TAM Tsz Kin 譚子健 |
| 2024.493 | Prince of Wales Hospital Cardiac Electrophysiology Procedural Registry | Prof. TAM Tsz Kin |
| 2025.268 | Cardio-neural pacing to modulate AV conduction in persistent AF patients – a feasibility study |
Prof. TAM Tsz Kin 譚子健 |
| 2018.405 | Intraoperative Use of Non-invasive Cardiac Output Monitoring versus Standard Fluid Management in Free Perforator Flap Surgery: A Randomized Pilot Trial |
Dr. TAM Suet Yee 談雪儀 |
| 2018.371 | Tricuspid regurgitation after cardiac implantable electronic device implantation | Dr. TAM Mark Tsz Kin |
| 2022.505 | Artificial intelligence to improve procedure safety of atrioventricular nodal reentrant tachycardia ablation – a retrospective feasibility study | Dr. TAM Mark Tsz Kin |
| 2023.332 | Leadless Pacemaker Registry |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2023.685 | A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation (AVANT GUARD) |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2022.456 | Atrial fibrillation ablation registry |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2023.406 | Drug - drug interaction (DDI) of direct oral anticoagulants database research |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2024.662 | A Stylet-Driven ICD Lead Intended for Conduction System Pacing IDE Study |
Prof. TAM Mark Tsz Kin 譚子健 |
| 2024.184 | Smartwatch paroxysmal arrhythmia detection compared with Holter - a multicenter controlled trial |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2024.179 | Leadless pacemaker implantation positions and its relationship with procedure efficacy and complication |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2024.350 | Catheter Ablation in Atrial Fibrillation Patients with Heart Failure with Preserved Ejection Fraction: an International, Prospective, Multi-center, Randomized Controlled study |
Prof. TAM Mark Tsz Kin 譚子健 |
| 2024.028 | Coronary study in patients undergoing AF ablation |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2025.045 | Cardiovascular physiological signal recording project |
Prof. TAM Mark Tsz Kin 譚子健 |
| 2009.114 | Randomised Controlled Trial of Two Algorithms for Weaning Cardiac Surgical Patients Using Adaptive Support Ventilation Mode. A Comparison of Duration of Ventilation | Dr Tam Man Kei Paul |
| 2025.218 | Clinical characteristics and outcomes of patients with Adult-Onset Still’s Disease (AOSD) in Hong Kong | Dr. TAM Lydia Ho Pui |
| 2021.663 | A retrospective study to evaluate the pulmonologist-pharmacist care model at the pharmacist respiratory clinic in an acute teaching hospital in Hong Kong. | Ms. TAM Lyanna Lik Yan |
| 2011.562 | An Open-Label Long-term Safety Extension Trial for Subjects with Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC) | Professor Tam Lai-Shan |
| 2009.409 | Traditional Chinese Medicine for Osteoarthritis of the Knee (TCM-OAK): A dose escalation study | Prof Tam Lai-Shan |
| 2011.050 | A Randomized, Double-Blind Phase 2b Study to Evaluate the Efficacy, Safety, and Tolerability of A-623 Administration in Subjects with Systemic Lupus Erythematosus | Professor Tam Lai-Shan |
| 2009.429 | A Phase 2A, Randomized, Double-Blind, Active and Placebo-Controlled Study of PF-04171327 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis | Dr. TAM Lai-Shan |
| 2012.082 | Periatricular and generalized bone loss in psoriatic arthritis | Prof. Tam Lai-Shan |
| 2011.558 | RAGE: a new therapeutic target and biomarker of rheumatoid arthritis | Professor Tam Lai-Shan |
| 2011.276 | Ankylosing spondylitis vascular study | Prof. TAM Lai-Shan |
| 2011.209 | Assessment of PROMIS Fatigue Bank with SLE-specfic items for use in an Asian SLE population in Hong Kong and Singapore | Prof. TAM Lai-Shan |
| 2011.174 | A stochastic cost-effectiveness analysis of an early inflammatory arthritis clinic in Hong Kong | Prof. TAM Lai-Shan |
| 2009.273 | Diagnostic and Prognostic Values of Anti-Ceclic Citullinated Peptide Antibodies in Chinese Population with Rheumatoid Arthritis | Prof. Tam Lai-Shan |
| 2009.583 | Function and expression profile of the nucleotide-blinding and oligoerization domain (NOD)-2 receptors in systemic lupus erythematosus | Prof Tam Lai Shan |
| 2011.547 | The role of Receptor for Advanced Glycation End Products (RAGE) in the pathogenesis of systemic Lupus erythematosus (SLE) | Professor TAM Lai Shan |
| 2010.250 | HMGB1: a danger signal molecule of the innate immune response for the immunopathogenesis of systemic lupus erythematosus | Professor TAM Lai Shan |
| 2008.475 | Innate pathogen recognition in systemic lupus erythematosus: Toll-like receptors and NOD-like receptors | Prof Tam Lai Shan |
| 2012.478 | Vascular effects of achieving minimal disease activity iin psoriatic arthritis - a 2 year prospetive cohort study | Prof. TAM Lai Shan |
| 2011.031 | The role of HMGB1 in the pathogenesis of systemic lupus erythematosus | Professor TAM Lai Shan |
| 2014.052 | Advanced 3-D Bioimaging Technology to improve vertebral fracture prediction in patients with glucocorticoid-induced osteoporosis | Prof. TAM Lai Shan |
Page 62 of 265.